Basic Information
RNALocate ID: | RLID:11002528 |
RNA Symbol: | hsa-miR-378a-3p |
Localization: | Extracellular vesicle |
RNA Information
RNA Name: | hsa-miR-378 |
RNA ID: | miRBase:MIMAT0000732 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22849433 |
Tissue/Cell Line: | HEK-293T cells |
Method: | Next-generation RNA sequencing |
Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002042 | Cytoplasm | LX-2 cells | 31272073 |
RLID:01002043 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002044 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002045 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002046 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11002516 | Exosome | Human cervical carcinoma cell line (HeLa|SiHa) | 25760330 |
RLID:11002517 | Exosome | Human milk | 28688106 |
RLID:11002518 | Exosome | Plasma | 29323722 |
RLID:11002519 | Exosome | Peripheral blood | 31746410 |
RLID:11002520 | Exosome | Serum | 18589210 |
RLID:11002521 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002522 | Exosome | HCC cell line (Hep3B|HepG2|PLC/PRF/5) | 21721029 |
RLID:11002523 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11002524 | Exosome | Brain tissue | 23382797 |
RLID:11002525 | Exosome | Plasma | 23663360 |
RLID:11002526 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002527 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
RLID:11002529 | Microvesicle | Plasma | 23077538 |
RLID:11002530 | Microvesicle | Seminal plasma | 23539611 |
RLID:11002531 | Microvesicle | Follicular fluid | 23666971 |
RLID:11002532 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000123 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Saliva|Tongue tissue | |
RLID-D:11000420 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-378a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-46454 |
MNDR | hsa-miR-378a-3p | Oral squamous cell carcinoma | MNDR-E-MI-46455 |
MNDR | hsa-miR-378a-3p | Small intestinal neuroendocrine tumor | MNDR-E-MI-46456 |
MNDR | hsa-miR-378a-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-46457 |
MNDR | hsa-miR-378a-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-46458 |
MNDR | hsa-miR-378a-3p | Lymphoma | MNDR-E-MI-46459 |
MNDR | hsa-miR-378a-3p | Lymphoma non-hodgkin | MNDR-E-MI-46460 |
MNDR | hsa-miR-378a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-46461 |
MNDR | hsa-miR-378a-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-46462 |
MNDR | hsa-miR-378a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-46463 |
MNDR | hsa-miR-378a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-46464 |
MNDR | hsa-miR-378a-3p | Her2-receptor positive breast cancer | MNDR-E-MI-46465 |
MNDR | hsa-miR-378a-3p | Breast cancer luminal | MNDR-E-MI-46466 |
MNDR | hsa-miR-378a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-46467 |
MNDR | hsa-miR-378a-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-46468 |
MNDR | hsa-miR-378a-3p | Small intestine cancer | MNDR-E-MI-46469 |
MNDR | hsa-miR-378a-3p | Dermatomyositis | MNDR-E-MI-46470 |
MNDR | hsa-miR-378a-3p | Prostate cancer | MNDR-E-MI-46471 |
MNDR | hsa-miR-378a-3p | Gastric cancer | MNDR-E-MI-46472 |
MNDR | hsa-miR-378a-3p | Alzheimer disease | MNDR-E-MI-46473 |
MNDR | hsa-miR-378a-3p | Myotonic dystrophy | MNDR-E-MI-46474 |
MNDR | hsa-miR-378a-3p | Head and neck cancer | MNDR-E-MI-46475 |
MNDR | hsa-miR-378a-3p | Leukemia | MNDR-E-MI-46476 |
MNDR | hsa-miR-378a-3p | Cardiovascular disease | MNDR-E-MI-46477 |
MNDR | hsa-miR-378a-3p | Lung cancer | MNDR-E-MI-46478 |
MNDR | hsa-miR-378a-3p | Parkinson disease | MNDR-E-MI-46479 |
MNDR | hsa-miR-378a-3p | Basal-like breast cancer | MNDR-E-MI-46480 |
MNDR | hsa-miR-378a-3p | Pituitary neoplasms | MNDR-E-MI-46481 |
MNDR | hsa-miR-378a-3p | Pancreatic cancer | MNDR-E-MI-46482 |
MNDR | hsa-miR-378a-3p | Melanoma | MNDR-E-MI-46483 |
MNDR | hsa-miR-378a-3p | Rectum adenocarcinoma | MNDR-E-MI-46484 |
MNDR | hsa-miR-378a-3p | Nephroblastoma | MNDR-E-MI-46485 |
MNDR | hsa-miR-378a-3p | Colon cancer | MNDR-E-MI-46486 |
MNDR | hsa-miR-378a-3p | Ischemic attack transient | MNDR-E-MI-46487 |
MNDR | hsa-miR-378a-3p | Colon adenocarcinoma | MNDR-E-MI-46488 |
MNDR | hsa-miR-378a-3p | Familial ovarian cancer | MNDR-E-MI-46489 |
MNDR | hsa-miR-378a-3p | Prostate adenocarcinoma | MNDR-E-MI-46490 |
MNDR | hsa-miR-378a-3p | Carcinoma ductal breast | MNDR-E-MI-46491 |
MNDR | hsa-miR-378a-3p | Glioblastoma | MNDR-E-MI-46492 |
MNDR | hsa-miR-378a-3p | Glioma | MNDR-E-MI-46493 |
MNDR | hsa-miR-378a-3p | Osteosarcoma | MNDR-E-MI-46494 |
MNDR | hsa-miR-378a-3p | Inclusion body myositis | MNDR-E-MI-46495 |
MNDR | hsa-miR-378a-3p | Breast carcinoma | MNDR-E-MI-46496 |
MNDR | hsa-miR-378a-3p | Liver cancer | MNDR-E-MI-46497 |
MNDR | hsa-miR-378a-3p | Cervical adenocarcinoma | MNDR-E-MI-46498 |
MNDR | hsa-miR-378a-3p | Gastric adenocarcinoma | MNDR-E-MI-46499 |
MNDR | hsa-miR-378a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-46500 |
MNDR | hsa-miR-378a-3p | Pituitary adenoma | MNDR-E-MI-46501 |
MNDR | hsa-miR-378a-3p | Lung squamous cell carcinoma | MNDR-E-MI-46502 |
MNDR | hsa-miR-378a-3p | Lung adenocarcinoma | MNDR-E-MI-46503 |
MNDR | hsa-miR-378a-3p | Ovarian carcinoma | MNDR-E-MI-46504 |
MNDR | hsa-miR-378a-3p | Bladder urothelial carcinoma | MNDR-E-MI-46505 |
MNDR | hsa-miR-378a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-46506 |
MNDR | hsa-miR-378a-3p | Carcinoma renal cell | MNDR-E-MI-46507 |
MNDR | hsa-miR-378a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-46508 |
MNDR | hsa-miR-378a-3p | Large cell carcinoma | MNDR-E-MI-46509 |
MNDR | hsa-miR-378a-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-46510 |
MNDR | hsa-miR-378a-3p | Cholangiocarcinoma | MNDR-E-MI-46511 |
MNDR | hsa-miR-378a-3p | Esophageal cancer | MNDR-E-MI-46512 |
MNDR | hsa-miR-378a-3p | Liver cirrhosis | MNDR-E-MI-46513 |
MNDR | hsa-miR-378a-3p | Synovial sarcoma | MNDR-E-MI-46514 |
MNDR | hsa-miR-378a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-46515 |
MNDR | hsa-miR-378a-3p | Encephalomyelitis | MNDR-E-MI-46516 |
MNDR | hsa-miR-378a-3p | Adenoma | MNDR-E-MI-46517 |
MNDR | hsa-miR-378a-3p | Breast invasive carcinoma | MNDR-E-MI-46518 |
MNDR | hsa-miR-378a-3p | Hepatocellular carcinoma | MNDR-E-MI-46519 |
MNDR | hsa-miR-378a-3p | Familiar ovarian carcinoma | MNDR-E-MI-46520 |
MNDR | hsa-miR-378a-3p | B-cell lymphoma | MNDR-E-MI-46521 |
MNDR | hsa-miR-378a-3p | Rheumatoid arthritis | MNDR-E-MI-46522 |
MNDR | hsa-miR-378a-3p | Retinoblastoma | MNDR-E-MI-46523 |
MNDR | hsa-miR-378a-3p | Ulcerative colitis | MNDR-E-MI-46524 |
MNDR | hsa-miR-378a-3p | Burkitt lymphoma | MNDR-E-MI-46525 |
MNDR | hsa-miR-378a-3p | Tonsil cancer | MNDR-E-MI-46526 |
MNDR | hsa-miR-378a-3p | Skin cutaneous melanoma | MNDR-E-MI-46527 |
MNDR | hsa-miR-378a-3p | Skin melanoma | MNDR-E-MI-46528 |
MNDR | hsa-miR-378a-3p | Acute myelocytic leukemia | MNDR-E-MI-46529 |
MNDR | hsa-miR-378a-3p | Colorectal cancer | MNDR-E-MI-46530 |
MNDR | hsa-miR-378a-3p | Sleep deprivation | MNDR-E-MI-46531 |
MNDR | hsa-miR-378a-3p | Breast cancer her3+ negative | MNDR-E-MI-46532 |
MNDR | hsa-miR-378a-3p | Duke A | MNDR-E-MI-46533 |
MNDR | hsa-miR-378a-3p | Tubulovillous adenoma | MNDR-E-MI-46534 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | CDK6 | Homo sapiens | RR00311163 |
TOP